CBD Producer Founder Introduces Cannabis Legalization History and CBD Bio-mechanism

Events
Mar.06.2023
2Firsrts had Ellen Tacher at APE. She was the first female cannabis entrepreneur in North Carolina, and she also discovered the biological mechanism of cannabis products.

David, Fort Lauderdale; edited by Mandy - On March 4, 2023, 2Firsrts interviewed Ellen Tacher, Prime Sunshine CBD's founder, which provides CBD products to help navigate people's wellness.

 

Ellen told 2Firsts the history of cannabis legalization. In the early 1990s, Ellen brought Woody Harrelson, an actor and cannabis lobbyer, onto the farm where Ellen worked before Woody was arrested for planting the French hemp seeds. Nevertheless, he was acquitted (one of his defenders, Steve Beshear, became the governor of Kentucky in a few years). Then the Farm President sued the Drug Enforcement Administration (DEA) and won. As a result, the farm founder co-wrote the first farm bill, and the legalization of hemp started in the United States.

 

Ellen also has found out the biological mechanism of cannabis working in human body. "Each human body has the endocannabinoid system, which is the largest medically identified system in the human body and requires cannabinoids. Due to the legalization of cannabis, pharmaceutical companies selling anxiety, sleep, and painkilling pills lost between 11-17% of revenue." Ellen also mentioned that the patients do not need any radiation or chemotherapy but cannabis to deal with stage two neuroblastoma.

 

Regarding the regulation of cannabis, Ellen thinks that Delta-8 will be illegal in the United States by the end of this year.

*This article is an original article of 2FIRSTS Technology Co., Ltd. The copyright and license rights belong to the company. Any entity or individual shall make link and credit 2FIRSTS when taking actions to copy, reprint or distribute the original article. The company retains the right to pursue its legal responsibility.

Shunhao Shares Reports 2025 Revenue of RMB 1.188 Billion, While Q1 2026 Net Profit Rises 49.94% and New Tobacco Operations Continue
Shunhao Shares Reports 2025 Revenue of RMB 1.188 Billion, While Q1 2026 Net Profit Rises 49.94% and New Tobacco Operations Continue
Shunhao Shares’ 2025 annual report summary and first-quarter 2026 report show that the company recorded 2025 revenue of RMB 1.188 billion, down 21.78% year on year, while net profit attributable to shareholders rose 30.00% to RMB 58.94 million. In the first quarter of 2026, revenue was RMB 291.51 million, down 10.34% year on year, while attributable net profit rose 49.94% to RMB 19.98 million.
Apr.29 by 2FIRSTS.ai
Altria and Juul Ask Court to Pause Antitrust Case Pending Ninth Circuit Review
Altria and Juul Ask Court to Pause Antitrust Case Pending Ninth Circuit Review
Altria and Juul are asking a California federal court to pause an antitrust case while they appeal a class certification ruling to the Ninth Circuit. The case alleges that Altria’s 2018 investment in Juul, a $12.8 billion deal for a 35% stake.
May.07 by 2FIRSTS.ai
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
British American Tobacco (BAT) shares rose sharply on May 12 after the U.S. Food and Drug Administration signaled it would deprioritize enforcement against certain unauthorized e-cigarette and nicotine pouch products with accepted premarket applications. Investors viewed the move as favoring established players such as BAT’s Vuse and Velo brands.
BAT
May.13
Trump’s Tobacco Investments and Industry Donations Draw Scrutiny as FDA Eases Vape and Nicotine Pouch Rules
Trump’s Tobacco Investments and Industry Donations Draw Scrutiny as FDA Eases Vape and Nicotine Pouch Rules
A report by KFF Health News says that as the Trump administration pursued a series of policies favorable to the nicotine and tobacco industry, President Donald Trump increased his holdings in tobacco companies while benefiting from substantial industry-linked political donations, prompting questions from public health advocates about potential conflicts of interest and regulatory direction.
Jun.12
ZYN ULTRA Expands Haypp’s U.S. E-Commerce Lineup With 9 mg Pouches
ZYN ULTRA Expands Haypp’s U.S. E-Commerce Lineup With 9 mg Pouches
Haypp Group said ZYN ULTRA became available nationwide in the United States on June 15 through its e-commerce platforms Nicokick.com and Northerner.com for verified adult nicotine consumers.
Jun.17
FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
FDA CTP issued a May 7 statement on accelerating product review and improving PMTA efficiency, but did not push it via official X and newsletter until May 13, one day after FDA Commissioner Marty Makary’s resignation was confirmed. FDA has not explained the delay, and no public evidence links it directly to the leadership change. The timing is notable given CTP’s usual 24-hour distribution practice.
Special Report
May.14